Clinical trial
Phase III Multicentric Trial Comparing Accelerated Partial Breast Irradiation (APBI) Versus Standard or Hypofractionated Whole Breast Irradiation in Low Risk of Local Recurrence of Breast Cancer
NCT01247233 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Multicentric Trial Comparing Accelerated Partial Breast Irradiation (APBI) Versus Standard or Hypofractionated Whole Breast Irradiation in Low Risk of Local Recurrence of Breast Cancer
- Lead sponsor
- UNICANCER
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 27, 2010
- Completion date
- October 31, 2025
- Enrollment
- 1,006 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, lumpectomy